Search for: "Merck "
Results 461 - 480
of 3,287
Sort by Relevance
|
Sort by Date
28 Feb 2019, 9:30 pm
Meanwhile, Merck acknowledged that patients without insurance are sometimes “paying the most” for prescription drugs, but the companies allegedly blamed the drug pricing system on pharmacy benefit managers and insurers who can buy drugs on discounts unavailable to the uninsured. [read post]
26 Feb 2019, 7:40 am
In 2006, the plaintiff filed a personal injury lawsuit against Merck in a state with a five-year statute of limitations. [read post]
25 Feb 2019, 9:43 am
In 2009, the plaintiff filed a personal injury lawsuit against Merck, the manufacturer of Vioxx. [read post]
23 Feb 2019, 7:15 am
Last month, business news outlets were reporting that stock prices for pharmaceutical firms Pfizer and Merck took a tumble after financial analysts downgraded the performance of both firms over concerns about impending patent cliffs or exclusivity issues - although more recent reports paint a mostly promising picture for the companies, thanks to upcoming acquisitions. [read post]
23 Feb 2019, 7:15 am
For Merck, although patent expiry wasn’t cited in a note from a pharmaceutical analyst from BMO, that analyst dropped Merck’s rating from outperform to market perform based on the expectation that the company’s blockbuster cancer drug Keytruda would face increased competition in the immuno-oncology field during 2019. [read post]
21 Feb 2019, 4:00 am
Periodically on Thursdays, we present a significant excerpt, usually from a recently published book or journal article. [read post]
8 Feb 2019, 3:02 am
Sued if you do, sued if you don’t: drugmaker faces lawsuits over failure to provide Fosamax warning that FDA told it not to provide [Jim Copland, James Beck on Merck Sharp & Dohme v. [read post]
5 Feb 2019, 7:34 am
Chairman Chuck Grassley and Ranking Member Ron Wyden sent the invitations to AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., Pfizer and Sanofi. [read post]
4 Feb 2019, 4:34 pm
“Court reinstates litigation against Merck over Vioxx”: Judy Greenwald of Business Insurance has this report on a ruling that a divided three-judge panel of the U.S. [read post]
29 Jan 2019, 6:32 am
” At The World and Everything in It (podcast), Mary Reichard discusses the oral arguments in Merck Sharp & Dohme Corp. v. [read post]
11 Jan 2019, 2:05 pm
The court heard argument this week in: Merck Sharp & Dohme Corp. v. [read post]
10 Jan 2019, 10:00 pm
Below is a brief summary of issues before the Court last week: Merck Sharp & Dohme Corp. v. [read post]
9 Jan 2019, 4:16 am
Elizabeth McCuskey has this blog’s analysis of Monday’s argument in Merck Sharp & Dohme v. [read post]
8 Jan 2019, 6:32 am
Merck raised impossibility pre-emption as a defense, arguing that the FDA had rejected Merck’s proposal to add a new warning similar to the one plaintiffs allege was warranted. [read post]
7 Jan 2019, 1:54 pm
In Merck v. [read post]
7 Jan 2019, 11:25 am
Supreme Court oral arguments: You can access at this link the transcript in Merck Sharp & Dohme Corp. v. [read post]
7 Jan 2019, 11:07 am
The transcript of oral argument in Merck Sharp & Dohme Corp. v. [read post]
7 Jan 2019, 3:58 am
The first is Merck Sharp & Dohme v. [read post]
6 Jan 2019, 9:00 am
On Monday, the justices hear oral argument in Merck Sharp & Dohme Corp. v. [read post]
4 Jan 2019, 10:37 am
Merck is No. 2., with 35 patents and 55 U.S. [read post]
